About Scailyte AG

Extracting knowledge from single-cell data to save millions of lives

A new and emerging type of analytical devices are producing rich data-sets by measuring hundreds of parameters from millions of individual cells. The resulting single-cell data holds the information needed for early disease detection but it requires sophisticated and innovative computational approaches in order to extract the relevant information.

We are addressing this problem by developing artificial intelligence (AI) software for single-cell data analysis. The underlying algorithms allow us to associate patterns in single-cell data with disease status, similar to how state-of-the-art methods for object recognition associate pixel patterns with objects. By partnering with hospitals to obtain single-cell patient data, we are building an AI-based pipeline for novel biomarker discovery, which will yield ultra-sensitive biomarkers for early and precise detection of a wide range of complex diseases. Further, we will provide a software solution, wrapping our AI technology for R&D customers from academia, pharma and clinics. By virtue of novelty and impact, our products have the potential to disrupt the healthcare market.




Dr. Peter Nestorov Founder & Chief Executive Officer

Peter studied Biochemistry in Tübingen and obtained a PhD in Genetics in Basel. He has experience in biomedical research and is an expert in genomics applications and technologies. Following his PhD, Peter took a sales role and developed a network of customers and industry partners from the Single-Cell Analysis market.

Peter is guiding Scailyte towards its mission by building relationships with partners and customers and by inspiring the team to deliver a solution that will save millions of lives.


Prof. Dr. Manfred Claassen Founder & Chief Scientific Officer

Manfred did parallel studies in Biochemistry and Computer Science at the University of Tübingen, followed by a PhD in machine learning at ETH Zurich. For his postdoctoral studies, Manfred moved to the Artificial Intelligence Laboratory in Stanford. In 2013 he became a group leader and Assistant Professor at ETH Zurich. His research is focused on computational single-cell biology in the context of cancer, infectious diseases and immune disorders.

Manfred is responsible for the scientific and clinical collaborations at Scailyte, which are fueling our technological and IP portfolios.


Dr. Dennis Göhlsdorf Founder, Chief Technology Officer &
Lead Software Engineer

Dennis has degrees in Biochemistry and Computer Science from the University of Tübingen and did his PhD in Neuro­informatics at ETH Zurich. His work focused on solving motion planning tasks using algorithms from machine learning and artificial intelligence. After that, he worked for Google as a software engineer and has more than 20 years of experience in software development.

Dennis is leading the product development and implementation of our artificial intelligence technology.


Dr. Daniel Sonnleithner Founder, Chief Operations Officer &
Senior Software Engineer

Daniel studied Mechanical Engineering, and Mechatronics in Karlsruhe. During his PhD in Neuroinformatics at ETH Zurich, he developed complex software systems. Afterwards, he worked for AWK, a Swiss IT consulting company, where he gained extensive experience in managing projects.

At Scailyte, Daniel is defining and maintaining the organizational processes, including quality management. Furthermore, Daniel is responsible for the IT infrastructure and the usability and appearance of our software service.


Anna Dimitrova, ACCA Chief Financial Officer

Anna has degrees in Economics and Finance from Sofia University and a professional ACCA qualification. She has more than 8 years experience as a business consultant and auditor in Big 4 companies (KPMG and PwC). In the last 5 years, Anna has served as an executive and a trusted business advisor in the NGO sector. She is currently the Financial Manager of a fast-growing B2B service provider.

Anna is managing Scailyte’s finances and plays a key role in defining and implementing our business and funding strategies.

Stefan Almestrand Commercial Advisor

Stefan studied chemical engineering and biotechnology at Mälardalen University and at the Royal institute of technology in Stockholm, Sweden. He spent 4 years in genomics and proteomics research focusing on hematological malignancies from Karolinska institutet. Following his research career, Stefan went to industry and has been working in EMEA and globally the last 10 years with sales, partnering, market and business development towards clinical diagnostics, precision medicine and companion diagnostics.


Stefan is advising on commercial strategy and tactics as well as in commercial operations and execution.


ETH Zürich

ETH Zürich is a university focusing on science, technology, engineering and mathematics in the city of Zürich, Switzerland. In the 2019 edition of the QS World University Rankings ETH Zürich is ranked 7th in the world.

Scailyte AG officially received the ETH Spin-off label by ETH Zürich. We will receive support in various activities for the initial years after incorporation.


>>venture>> is an initiative of the ETH Zurich, McKinsey & Company Switzerland, Knecht Holding, the innovation promotion agency CTI, and École Polytechnique Fédérale de Lausanne (EPFL). The leading Swiss-wide startup competition supports young entrepreneurs in founding a company.

Scailyte participated in the 2017 »venture» competition and received coaching and valuable feedback from experts and investors. Our project was ranked among the Top25 business ideas from more than 100 projects in this track.


Innosuisse is the Swiss Confederation’s innovation promotion agency. It provides consultancy, networking services and financial resources to help turn scientific research into economic results.

Scailyte is part of the Inosuisse coaching program. We have passed the Coaching Acceptance in November 2017 and we are now working intensively with our Inosuisse coach to fine-tune our business plan and implement the go-to-market strategy.

Venture Kick

Venture Kick aims for an early detection and promotion of promising business ideas at Swiss universities and schools of higher education.

Scailyte is receiving coaching and financial support from Venture Kick.